A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Clinical trial NCT06668805 · RECRUITING
Trial details
- NCT number
- NCT06668805
- Sponsor
- BioMarin Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-22
- Primary completion
- 2027-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.